CNS Drugs

, Volume 17, Issue 3, pp 203–211 | Cite as

Opinion and Evidence in Neurology and Psychiatry

From the World Literature
  • 10 Downloads

Reference

  1. 1.
    Clarke CE, Guttman M. Dopamine agonist monotherapy in Parkinson’s disease. Lancet 2002 Nov 30; 360: 1767–9PubMedCrossRefGoogle Scholar

Reference

  1. 2.
    Bodkin JA, Amsterdam JD. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry 2002 Nov; 159: 1869–75PubMedCrossRefGoogle Scholar

Reference

  1. 3.
    Martenyi F, Brown EB, Zhang H, et al. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry 2002 Oct; 181: 315–20PubMedCrossRefGoogle Scholar

Reference

  1. 4.
    Patel V, Chisholm D, Rabe-Hesketh S, et al. Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. Lancet 2003 Jan 4; 361: 33–9PubMedCrossRefGoogle Scholar

ReferenceS

  1. 5.
    Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003 Jan 2; 348: 15–23PubMedCrossRefGoogle Scholar
  2. 6.
    von Andrian UH, Engelhardt B. α-(4) Integrins as therapeutic targets in autoimmune disease. N Engl J Med 2003 Jan 2; 348: 68–72CrossRefGoogle Scholar

Reference

  1. 7.
    Trinh N-H, Hoblyn J, Mohanty S, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatrie symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003 Jan 8; 289: 210–6PubMedCrossRefGoogle Scholar

Reference

  1. 8.
    Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of anti-depressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003 Jan 1; 289: 56–64PubMedCrossRefGoogle Scholar

Reference

  1. 9.
    Tronvik E, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003 Jan 1; 289: 65–9PubMedCrossRefGoogle Scholar

Reference

  1. 10.
    Loop T, Priebe H-J. Prospective, randomized cost analysis of anesthesia with remifentanil combined with propofol, desflurane or sevoflurane for otorhinolaryngeal surgery. Acta Anaesthesiol Scand 2002 Nov; 46: 1251–60PubMedCrossRefGoogle Scholar

References

  1. 11.
    McLaurin J, Cecal R, Kierstead ME, et al. Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nat Med 2002 Nov: 8: 1263–9PubMedCrossRefGoogle Scholar
  2. 12.
    Hock C, Konietzko U, Papassotiropoulos A, et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med 2002 Nov; 8: 1270–5PubMedCrossRefGoogle Scholar
  3. 13.
    Haass C. New hope for Alzheimer disease vaccine. Nat Med 2002 Nov; 8: 1195–6PubMedCrossRefGoogle Scholar

Reference

  1. 14.
    Sicotte NL, Liva SM, Klutch, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002 Oct; 52: 421–8PubMedCrossRefGoogle Scholar

Reference

  1. 15.
    Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002 Oct; 50: 1629–37PubMedCrossRefGoogle Scholar

Reference

  1. 16.
    Hiemke C, Peled A, Jabarin M, et al. Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects. J Clin Psychopharmacol 2002 Oct; 22: 502–6PubMedCrossRefGoogle Scholar

Reference

  1. 17.
    Okun MS, Walter BL, McDonald WM, et al. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 2002 Nov; 59: 1750–3PubMedCrossRefGoogle Scholar

References

  1. 18.
    de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002 Nov 14; 347: 1549–56PubMedCrossRefGoogle Scholar
  2. 19.
    Tunkel AR, Scheid WM. Corticosteroids for everyone with meningitis? N Engl J Med 2002 Nov 14; 347: 1613–5PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Personalised recommendations